QIAGEN NV
(NYSE : QGEN)

( )
QGEN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
INOInovio Pharmaceuticals, Inc. 0.47%23.386.3%$1311.41m
TMOThermo Fisher Scientific, Inc. -1.32%382.561.0%$555.58m
DXCMDexCom, Inc. -0.20%439.648.2%$525.71m
MDTMedtronic Plc 0.77%90.820.6%$523.27m
BDXBecton, Dickinson & Co. -0.50%257.331.0%$495.38m
ABTAbbott Laboratories -0.67%93.040.8%$494.90m
DHRDanaher Corp. -0.95%183.700.7%$446.67m
BSXBoston Scientific Corp. 0.52%34.681.0%$429.44m
QDELQuidel Corp. 0.69%246.647.7%$412.12m
ISRGIntuitive Surgical, Inc. 0.24%575.872.4%$333.95m
SYKStryker Corp. 0.07%177.891.3%$308.55m
BAXBaxter International, Inc. -0.53%85.241.8%$275.66m
ALGNAlign Technology, Inc. -0.29%273.296.4%$224.28m
ZBHZimmer Biomet Holdings, Inc. 1.52%119.431.7%$205.29m
BIOBio-Rad Laboratories, Inc. -0.03%477.902.9%$199.18m

Company Profile

QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.